- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
ALTEOGEN
Market Cap: ₩17.8t
A bio company, focuses on developing long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars.
A196170
₩255,500.00
7D
-8.6%
1Y
-29.8%
SK Biopharmaceuticals
Market Cap: ₩6.1t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩78,200.00
7D
-6.7%
1Y
-27.2%
Oscotec
Market Cap: ₩1.3t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩34,350.00
7D
-1.3%
1Y
-13.4%
JW Shinyak
Market Cap: ₩195.6b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩3,500.00
7D
-9.4%
1Y
147.3%